OpenLegislation

Regulation 8 Amendment to regulation 250

Original text. Later amendments are not shown.

In regulation 250 (exceptions to regulation 249)f1, after paragraph (4A) insert—

“(4B)

A person may, in the course of a business consisting (wholly or partly) of manufacturing medicinal products, or of selling products by way of wholesale dealing, sell or supply by way of wholesale dealing a naloxone product that is a prescription only medicine to—

(a)

providers of drug treatment services that have arrangements as mentioned in regulation 237A(2)(a);

(b)

the medical services of His Majesty’s forces;

(c)

the bodies mentioned in regulation 237A(2)(c); and

(d)

local naloxone providers.”.

Annotations

Footnotes

f1

Amended by S.I. 2020/1125 (S.R. 2020/349).